Intima Bioscience Presents Landmark Findings on CISH Immune Checkpoint at AACR 2025 Intima Bioscience unveils groundbreaking data from a pioneering trial targeting CISH, an immune checkpoint, for metastatic colorectal cancer at AACR 2025.

Intima Bioscience Presents Landmark Findings on CISH Immune Checkpoint at AACR 2025 #United_States #New_York #Colorectal_Cancer #CISH_immune_checkpoint #Intima_Bioscience